Dermira
AcquiredDermira is a biotech company in Menlo Park, United States, founded in 2010. It has raised $202.0M across 5 rounds, most recently a $125.0M Venture Round in October 2014.
Bringing biotech ingenuity to medical dermatology
- Headquarters
- Menlo Park, California
- Employees
- 201–500
- Founded
- 2010
- Business Model
- B2B
- Website
- dermira.com
- Total Funding
- $202.0M
- Last Round
- $125.0M Venture RoundOct 2014
- Rounds
- 5
- Acquisition Date
- Jan 2020
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 5 funding rounds and 5 investors for this company. The full record is or through the API.
About
Dermira was a specialty biopharmaceutical company dedicated to developing differentiated therapies for chronic skin conditions. Based in Menlo Park, California, Dermira developed lebrikizumab (an IL-13 antibody for atopic dermatitis) and Qbrexza (for hyperhidrosis). The company was acquired by Eli Lilly for approximately $1.1 billion in 2020.
Summary
It lists 201–500 employees. It has raised $202.0M in total across 5 rounds, most recently a $125.0M Venture Round in Oct 2014. Investors include Bay City Capital, Eli Lilly and Maruho Co., Ltd..
Funding & Exit History
Jan 2020
Sign up to see all 6 events
Funding: Seed through Venture Round. Amounts, valuations, and investors where available.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/dermira"><img src="https://indexed.vc/api/badge/company/dermira" alt="Dermira on Indexed.vc" width="260" height="76" /></a>